iodixanol has been researched along with Common Variable Immunodeficiency in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Common Variable Immunodeficiency: Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Iodixanol gradients were shown to best preserve host lipoprotein-virus complexes, and all HCV RNA was found at densities below 1." | 1.33 | Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. ( Bassendine, MF; Burt, AD; Martin, C; Nielsen, SU; Pumeechockchai, W; Toms, GL, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, SU | 1 |
| Bassendine, MF | 1 |
| Burt, AD | 1 |
| Martin, C | 1 |
| Pumeechockchai, W | 1 |
| Toms, GL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)[NCT02768545] | Phase 4 | 12 participants (Anticipated) | Interventional | 2013-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for iodixanol and Common Variable Immunodeficiency
| Article | Year |
|---|---|
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.
Topics: Apolipoproteins B; Apolipoproteins E; Bromides; Centrifugation, Density Gradient; Common Variable Im | 2006 |